Shanghai InnoStar Bio-tech Co (SHSE:688710) Total Liabilities: ¥996.3 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688710 Shanghai InnoStar Bio-tech Co Ltd SHSE:688710
33 GF Score
Price ¥75.04
! 8 Warning Signs
View Full Analysis

What is Shanghai InnoStar Bio-tech Co Total Liabilities?

Shanghai InnoStar Bio-tech Co SHSE:688710 +8.28% 33 Total Liabilities is ¥996.3 Mil as of Mar. 2026. GuruFocus rates SHSE:688710 with a GF Score™ of 33/100. The stock has 8 warning signs investors should review.

Shanghai InnoStar Bio-tech Co's Total Liabilities for the quarter that ended in Mar. 2026 was ¥996.3 Mil.

Shanghai InnoStar Bio-tech Co's quarterly Total Liabilities increased from Sep. 2025 (¥799.08 Mil) to Dec. 2025 (¥891.41 Mil) and increased from Dec. 2025 (¥891.41 Mil) to Mar. 2026 (¥996.27 Mil).

Shanghai InnoStar Bio-tech Co's annual Total Liabilities declined from Dec. 2023 (¥1,135.95 Mil) to Dec. 2024 (¥817.42 Mil) but then increased from Dec. 2024 (¥817.42 Mil) to Dec. 2025 (¥891.41 Mil).

Shanghai InnoStar Bio-tech Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Shanghai InnoStar Bio-tech Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai InnoStar Bio-tech Co Total Liabilities Chart

Shanghai InnoStar Bio-tech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 1,048.19 1,176.70 1,135.95 817.42 891.41

Shanghai InnoStar Bio-tech Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 827.61 849.28 799.08 891.41 996.27
SHSE:688710
33GF Score
Shanghai InnoStar Bio-tech Co Ltd SHSE:688710
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai InnoStar Bio-tech Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shanghai InnoStar Bio-tech Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=712.192+(104.59+74.632
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=891.4

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=3253.43-2362.016
=891.4

Shanghai InnoStar Bio-tech Co's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=807.641+(118.059+70.57
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=996.3

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=3372.38-2376.109
=996.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ¥996.3 Mil mean?
Shanghai InnoStar Bio-tech Co (SHSE:688710) has a Total Liabilities of ¥996.3 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shanghai InnoStar Bio-tech Co and its competitors.
Is Shanghai InnoStar Bio-tech Co's Total Liabilities too high?
Shanghai InnoStar Bio-tech Co's current Total Liabilities is ¥996.3 Mil. Overall, Shanghai InnoStar Bio-tech Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai InnoStar Bio-tech Co's Total Liabilities compare to LLY and JNJ?
Shanghai InnoStar Bio-tech Co's Total Liabilities of ¥996.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shanghai InnoStar Bio-tech Co and its competitors. Shanghai InnoStar Bio-tech Co's current Total Liabilities is ¥996.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai InnoStar Bio-tech Co stock overvalued right now?
Shanghai InnoStar Bio-tech Co (SHSE:688710) has a current Total Liabilities of ¥996.3 Mil. The current Total Liabilities is ¥996.3 Mil. Shanghai InnoStar Bio-tech Co's overall GF Score™ is 33/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Shanghai InnoStar Bio-tech Co (SHSE:688710), the current Total Liabilities is ¥996.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shanghai InnoStar Bio-tech Co Business Description

Address No. 199 Guo Shoujing Road, Room 106, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai InnoStar Bio-tech Co Ltd is a comprehensive research and development services (CRO) enterprise that specializes in providing biomedical non-clinical research services.
33GF Score

Get the complete analysis for SHSE:688710

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥75.04
Price